Treating opioid dependence
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Missing the point
The recent controversy embroiling the Richmond injecting room is overshadowing its positive community impact.
Protecting transplant patients
Combating a virus that can cause disease and life-threatening transplant complications is the focus of Eureka Prize-winning research.
Going back to nature over dengue
Eco solutions may hold the answer to controlling the spread of the mosquito-borne virus in Malaysia.
A call for action, from Townsville to Tuvalu
A new report says policymakers need to address the impact of environmental changes on health in Australia and the Asia-Pacific region.
Ebola bites back
Urgent action is needed to combat the second-biggest outbreak of the deadly virus that's claimed more than 1500 lives.
The ethics of experimental vaccines
Deliberately infecting people with a disease-causing agent as part of medical research can be ethically acceptable, and even necessary.
A guide to flu vaccines
The adjuvanted flu vaccine is free for over-65s and offers better protection than the standard vaccine. Here's what the research says.
Committed to a sustainable future
Monash is playing a leading role in the push to meet the United Nations' Sustainable Development Goals.
Monash research snapshots
Read about the latest research coming out of Monash, from the sustainability of global fisheries to mood based apps fighting depression and more.
For the greater good?
Sometimes, improving public health can mean infringing on people’s rights and compromising their interests.
A self-defeating success story
A global program in which mosquitoes are implanted with a common bacteria is preventing the spread of viruses such as dengue, Zika and chikungunya – and could help tens of millions of people.
Sex, man flu and the water flea
There's a lot we can learn about ourselves from this tiny crustacean, including why men might well be more susceptible to the flu.
A prescription for prevention
HIV is no longer a death sentence, but the epidemic that has claimed nearly 40 million lives and ruined countless others isn’t over yet.
New flu vaccines for the over-65s
Two free flu vaccines will improve protection for older people, but like those already available, they're not perfect.
Sleepwalking towards an antibiotic apocalypse
Despite dire warnings of a looming antibiotic resistance crisis, the issue has failed to capture the public imagination.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Revealed: our cellular guardians
An immunology mystery surrounding the cellular basis for our biological uniqueness has been solved – with groundbreaking implications for treating autoimmune diseases.
Why our computing devices seem to slow down with age
There are a few reasons why smartphones, tablets and PCs start to seem less snappy over time.
Professor of Infectious Diseases Epidemiology
Associate Professor, Monash Sustainable Development Institute
Associate Professor of Infectious Diseases, Medicine
Finkel Professor of Global Health and Director of Global and Women’s Health, School of Public Health and Preventive Medicine
Associate Professor, Law Research Services
Associate Professor of Sociology
Lecturer, School of Biological Sciences
Professor, Monash Bioethics Centre
Professor of Medicine and Director of the Centre for Inflammatory Diseases
Professor and Director, World Mosquito Program
Associate Professor, Biochemistry and Molecular Biology
Deputy Director, Monash Addiction Research Centre
Senior Lecturer, School of Science, Monash Malaysia
Professor (Research), Microbiology